Recombinant Human Annexin A13/ANXA13
Source: E.coli. MW :35.4kD. Recombinant Human Annexin A13 is produced by our E.coli expression system and the target gene encoding Gly2-His316 is expressed. Annexin A13 (ANXA13) belongs to the annexin family which plays a role in phospholipase inhibition, cytoskeletal interactions, intracellular signal transduction pathways and regulation of cellular growth. ANXA13 contains four annexin repeats and a pair of annexin repeats may form one binding site for calcium and phospholipid. ANXA13 is highly expressed in intestinal and kidney epithelial cells. The specific function of ANXA13 has not yet been determined; however it is associated with the plasma membrane of undifferentiated, proliferating crypt epithelial cells as well as differentiated villus enterocytes.
Product Specifications
Gene Name
ANXA13
Gene ID
312
UniProt
P27216
Components
Supplied as a 0.2 μm filtered solution of 20mM TrisHCl, 100mM NaCl, 10% Glycerol, pH 8.0.
Shipping Conditions
The product is shipped on dry ice/ice packs.
Storage Conditions
Store at -20°C, stable for 6 months after receipt. Please minimize freeze-thaw cycles.
Applications Notes
Endotoxin : Less than 0.1 ng/μg (1 IEU/μg) as determined by LAL test.
Amino Acids
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
VEGFR-2, phosphorylated (Tyr996) (Vascular Endothelial Growth Factor Receptor 2, VEGFR-2, Kinase Insert Domain Receptor, Protein-tyrosine Kinase Receptor Flk-1, Fetal Liver Kinase 1, FLK-1, CD309 antigen, KDR, FLK1) (AP) discontinued
LYVE1, CT (Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1, Cell Surface Retention Sequence-binding Protein 1, CRSBP-1, Hyaluronic Acid Receptor, Extracellular Link Domain-containing Protein 1, LYVE-1, CRSBP1, HAR, XLKD1, UNQ230/PRO263) (Biotin) discontinued